医学
肺炎
重症监护医学
社区获得性肺炎
肺炎链球菌
经验性治疗
抗生素
疾病
抗生素耐药性
肺病
养生
内科学
肺
病理
替代医学
微生物学
生物
作者
Charles Lanks,Ali I. Musani,David Hsia
标识
DOI:10.1016/j.mcna.2018.12.008
摘要
Pneumonia is among the leading causes of morbidity and mortality worldwide. Although Streptococcus pneumoniae is the most likely cause in most cases, the variety of potential pathogens can make choosing a management strategy a complex endeavor. The setting in which pneumonia is acquired heavily influences diagnostic and therapeutic choices. Because the causative organism is typically unknown early on, timely administration of empiric antibiotics is a cornerstone of pneumonia management. Disease severity and rates of antibiotic resistance should be carefully considered when choosing an empiric regimen. When complications arise, further work-up and consultation with a pulmonary specialist may be necessary.
科研通智能强力驱动
Strongly Powered by AbleSci AI